Patent Application
Utility
App. No. 12/799,401
· Confirmation No. 4394
Azithromycin for the treatment of nodular acne
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2013-04-04 | INTV.SUM.EX |
Examiner initiated interview summary (PTOL-413B) | 2 | View | |
| 2013-04-04 | ABN |
Abandonment | 1 | View | |
| 2012-09-07 | CTNF |
Non-Final Rejection | 6 | View | |
| 2012-09-07 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2012-09-07 | 1449 |
List of References cited by applicant and considered by examiner | 3 | View | |
| 2012-02-16 | RCEX |
Request for Continued Examination (RCE) | 1 | View | |
| 2012-02-16 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2012-02-16 | CLM |
Claims | 6 | View | |
| 2012-02-16 | REM |
Applicant Arguments/Remarks Made in an Amendment | 8 | View | |
| 2012-02-16 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2012-02-16 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2011-12-07 | CTFR |
Final Rejection | 8 | View | |
| 2011-12-07 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2011-11-22 | DISQ |
Terminal Disclaimer review decision | 1 | View | |
| 2011-10-25 | DIST |
Terminal Disclaimer Filed | 2 | View | |
| 2011-10-25 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2011-10-25 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2011-10-25 | CLM |
Claims | 6 | View | |
| 2011-10-25 | REM |
Applicant Arguments/Remarks Made in an Amendment | 7 | View | |
| 2011-10-25 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2011-07-25 | CTNF |
Non-Final Rejection | 8 | View | |
| 2011-07-25 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2011-07-25 | 1449 |
List of References cited by applicant and considered by examiner | 3 | View | |
| 2010-08-26 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2010-05-18 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 3 | View | |
| 2010-05-18 | TRAN.LET |
Transmittal Letter | 3 | View | |
| 2010-05-18 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2010-05-14 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2010-04-23 | TRNA |
Transmittal of New Application | 3 | View | |
| 2010-04-23 | SPEC |
Specification | 16 | View | |
| 2010-04-23 | CLM |
Claims | 5 | View | |
| 2010-04-23 | ABST |
Abstract | 1 | View | |
| 2010-04-23 | OATH |
Oath or Declaration filed | 3 | View | |
| 2010-04-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2010-04-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2010-04-23 | 136A |
Authorization for Extension of Time all replies | 3 | View |
Inventors
David Wade Osborne
Santa Rosa, CA
Gordon Jay Dow
Santa Rosa, CA
Bhaskar Chaudhuri
San Jose, CA
Barry Calvarese
Menlo Park, CA
Attorneys & Agents of Record
Classification
USPC
514/28
A61K31/7052
A61K31/205
A61K2300/00
Prosecution
- Examiner
- PESELEV, ELLI
- Art Unit
- 1623
- Customer No.
- 29085
- Docket No.
- 767.0222
- Confirmation No.
- 4394
Publication
- Pub. No.
- US20100216732A1
- Pub. Date
- 2010-08-26
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
from
ATON PHARMA, INC., A DELAWARE CORPORATION,
CORIA LABORATORIES, LTD., A DELAWARE CORPORATION,
DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION,
PRESTWICK PHARMACEUTICALS, INC., A DELAWARE CORPORATION,
VALEANT BIOMEDICALS, INC., A DELAWARE CORPORATION,
VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC, A DELAWARE LLC
SECURITY AGREEMENT
Recorded 2011-07-18
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS NORTH AMERICA,
CORIA LABORATORIES, LTD.,
DOW PHARMACEUTICAL SCIENCES, INC.,
ATON PHARMA, INC.
PATENT SECURITY RELEASE AGREEMENT
Recorded 2011-03-14
from
ATON PHARMA, INC.,
CORIA LABORATORIES, LTD.,
DOW PHARMACEUTICAL SCIENCES, INC.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS NORTH AMERICA
SECURITY AGREEMENT
Recorded 2010-10-04
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 12/799,401
- Filed
- 2010-04-23
- Pub. No.
- US20100216732A1
- Examiner
- PESELEV, ELLI
- Art Unit
- 1623
External Links